Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Recruiting · NCT07686263 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 3 | 2026-09-28 | NCT07686263 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 8 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atlanta Center for Medical Research | Atlanta | United States | 24 |
| Health Synergy Clinical Research | West Palm Beach | United States | 17 |
| Pillar Clinical Research - Bentonville | Bentonville | United States | 2 |
| Pillar Clinical Research - Richardson | Richardson | United States | 8 |
| Pillar Clinical Research -Chicago | Chicago | United States | 5 |
| Pillar Clinical Research- Little Rock | Little Rock | United States | 7 |
| Research Centers of America ( Hollywood ) | Hollywood | United States | 4 |